Entera Bio (ENTX) News Today $1.94 -0.02 (-1.02%) Closing price 04:00 PM EasternExtended Trading$1.95 +0.01 (+0.52%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENTX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Entera Bio Ltd. (NASDAQ:ENTX) Short Interest UpdateAugust 21, 2025 | marketbeat.comQ3 Earnings Estimate for Entera Bio Issued By HC WainwrightAugust 16, 2025 | marketbeat.comQ1 Earnings Estimate for Entera Bio Issued By HC WainwrightAugust 15, 2025 | marketbeat.comHC Wainwright Upgrades Entera Bio (NASDAQ:ENTX) to "Strong-Buy"August 14, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Announces Earnings ResultsAugust 11, 2025 | marketbeat.comEntera Bio Second Quarter 2025 Earnings: US$0.057 loss per share (vs US$0.058 loss in 2Q 2024)August 11, 2025 | finance.yahoo.comEntera Bio Reports Q2 2025 Financial Results and Strategic ProgressAugust 8, 2025 | tipranks.comEntera Bio Beats Q2 EPS EstimatesAugust 8, 2025 | fool.comEntera Bio Announces Second Quarter 2025 Financial Results and Business UpdatesAugust 8, 2025 | globenewswire.comEntera Bio (ENTX) Projected to Post Earnings on FridayAugust 1, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Up 10.8% - What's Next?July 29, 2025 | marketbeat.comEntera Bio stock surges after FDA agrees on BMD endpoint for EB613July 28, 2025 | investing.comEntera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with OsteoporosisJuly 28, 2025 | globenewswire.comEntera Bio Stock Price, Quotes and Forecasts | NASDAQ:ENTX | BenzingaJune 6, 2025 | benzinga.comNorthern Trust Corp Acquires New Position in Entera Bio Ltd. (NASDAQ:ENTX)June 1, 2025 | marketbeat.comKnoll Capital Management LLC Grows Holdings in Entera Bio Ltd. (NASDAQ:ENTX)May 23, 2025 | marketbeat.comEntera Bio Reports Q1 2025 Financial Results and Strategic DevelopmentsMay 16, 2025 | tipranks.comEntera Bio (NASDAQ:ENTX) Announces Quarterly Earnings ResultsMay 12, 2025 | marketbeat.comEntera Bio Ltd.: Entera Bio Announces First Quarter 2025 Financial Results and Business UpdatesMay 10, 2025 | finanznachrichten.deEntera Bio Announces First Quarter 2025 Financial Results and Business UpdatesMay 9, 2025 | globenewswire.comEntera Bio (ENTX) to Release Earnings on FridayMay 4, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Up 5.6% - Time to Buy?April 26, 2025 | marketbeat.comEntera Bio announces highlights from presentation at WCO-IFO-ESCEO on EB613April 15, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 13.7%April 4, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Issues Earnings ResultsMarch 29, 2025 | marketbeat.comEntera Bio Reports Transformative Year in 2024March 28, 2025 | tipranks.comEntera Bio Announces Full Year 2024 Financial Results and Provides Business UpdatesMarch 28, 2025 | globenewswire.comEntera Bio Ltd.March 26, 2025 | wsj.comEntera Bio's (ENTX) "Buy" Rating Reiterated at HC WainwrightMarch 19, 2025 | marketbeat.comOpko Health, Entera Bio to Collaborate on Tablet for Obesity, Metabolic and Fibrotic DisordersMarch 17, 2025 | marketwatch.comOpko Health, Entera Bio enter collaboration agreement for GLP-1/glucagon peptideMarch 17, 2025 | markets.businessinsider.comOpko Health, Entera Bio enter into collaboration agreementMarch 17, 2025 | markets.businessinsider.comEntera Bio Collaborates with OPKO for Oral GLP-1/GlucagonMarch 17, 2025 | tipranks.comOPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic DisordersMarch 17, 2025 | globenewswire.comEntera Bio (ENTX) Expected to Announce Quarterly Earnings on FridayMarch 7, 2025 | marketbeat.comEntera Bio (NASDAQ:ENTX) Trading Down 1.4% - Time to Sell?February 25, 2025 | marketbeat.comEntera Bio to Participate in Upcoming EventsFebruary 24, 2025 | globenewswire.comEntera Bio announces acceptance of EB613 abstracts for WCO-IOF-ESCEOFebruary 19, 2025 | markets.businessinsider.comShort Interest in Entera Bio Ltd. (NASDAQ:ENTX) Declines By 31.6%February 15, 2025 | marketbeat.comIs Entera Bio (NASDAQ:ENTX) In A Good Position To Deliver On Growth Plans?February 6, 2025 | uk.finance.yahoo.comPerigon Wealth Management LLC Takes $325,000 Position in Entera Bio Ltd. (NASDAQ:ENTX)February 3, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Growth in Short InterestJanuary 31, 2025 | marketbeat.comEntera Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceJanuary 27, 2025 | globenewswire.comEntera Bio (NASDAQ:ENTX) Stock Price Up 1.1% - Still a Buy?January 7, 2025 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Significant Increase in Short InterestDecember 1, 2024 | marketbeat.comEntera Bio Ltd. (NASDAQ:ENTX) Sees Large Increase in Short InterestNovember 17, 2024 | marketbeat.comHC Wainwright Decreases Earnings Estimates for Entera BioNovember 14, 2024 | marketbeat.comEntera Bio Buy Rating: Strong Financials, Strategic Developments, and Promising Pipeline Drive Analyst ConfidenceNovember 12, 2024 | markets.businessinsider.comEntera Bio's (ENTX) "Buy" Rating Reaffirmed at HC WainwrightNovember 11, 2024 | marketbeat.comEntera Bio Highlights Q3 2024 Financials and FDA AnticipationNovember 9, 2024 | markets.businessinsider.com Get Entera Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for ENTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ENTX Media Mentions By Week ENTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENTX News Sentiment▼1.890.99▲Average Medical News Sentiment ENTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENTX Articles This Week▼11▲ENTX Articles Average Week Get the Latest News and Ratings for ENTX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Entera Bio and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Capricor Therapeutics News Today Zhengye Biotechnology News Today ADC Therapeutics News Today Benitec Biopharma News Today 4D Molecular Therapeutics News Today Inhibrx Biosciences News Today Candel Therapeutics News Today Larimar Therapeutics News Today Rocket Pharmaceuticals News Today Amarin News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ENTX) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredSmall Washington, DC Group Could Crash US StocksNew Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Entera Bio Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Entera Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access